| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/01/2006 | EP1629007A2 Novel peptides that bind to the erythropoietin receptor |
| 03/01/2006 | EP1629002A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 03/01/2006 | EP1629001A2 Blys antagonists and uses thereof |
| 03/01/2006 | EP1629000A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/01/2006 | EP1628999A2 Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628991A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 03/01/2006 | EP1628687A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 03/01/2006 | EP1628686A2 Spacer moiety for poly (ethylene glycol)-modified peptides |
| 03/01/2006 | EP1628678A2 Methods and compositions for treating eye disorders |
| 03/01/2006 | EP1628677A1 Protein stabilization in solution |
| 03/01/2006 | EP1628676A1 Grf analog compositions and their use |
| 03/01/2006 | EP1628675A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 03/01/2006 | EP1628674A2 Protease inhibitors for coronaviruses and sars-cov and the use thereof |
| 03/01/2006 | EP1628659A1 Use of poly-aminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 03/01/2006 | EP1628641A2 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 03/01/2006 | EP1628631A2 Methods of treating hyperproliferative cell disorders |
| 03/01/2006 | EP1628630A2 Method of mitigating the adverse effects of il-2 |
| 03/01/2006 | EP1628629A2 Polynucleotides and polypeptides associated with the nf-kb pathway |
| 03/01/2006 | EP1628624A2 Methods and compositions for interferon therapy |
| 03/01/2006 | EP1628621A2 Polymeric conjugates for tissue activated drug delivery |
| 03/01/2006 | EP1628618A2 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 03/01/2006 | EP1628530A2 Methods and compositions for the prevention and treatment of sepsis |
| 03/01/2006 | EP1528922B1 Use of treosulfan and derivatives thereof for treating multiple sclerosis |
| 03/01/2006 | EP1417309A4 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 03/01/2006 | EP1389234B1 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 03/01/2006 | EP1333823A4 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 03/01/2006 | EP1311672B1 tRNA-derived inhibitors of HIV reverse transcriptase |
| 03/01/2006 | EP1290205B1 Duplexed parvovirus vectors |
| 03/01/2006 | EP1263365A4 Malleable paste with allograft bone reinforcement for filling bone defects |
| 03/01/2006 | EP1244433B1 Use of non-human SHIP2 knock-out mammals |
| 03/01/2006 | EP1206577B1 Binary encoded sequence tags |
| 03/01/2006 | EP1173764B1 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12 |
| 03/01/2006 | EP1169465B1 Two-step immunization procedure against chlamydia infection |
| 03/01/2006 | EP1162991B1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 03/01/2006 | EP1143983B1 Spray delivery of cells |
| 03/01/2006 | EP1141252B1 Human delta 5-desaturase gene and uses thereof |
| 03/01/2006 | EP1133285B1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 03/01/2006 | EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 03/01/2006 | EP1097228B1 Method of making proteins in transformed yeast cells |
| 03/01/2006 | EP1049488B1 Method of and compositions for immunization with the pseudomonas aeruginosa v-antigen |
| 03/01/2006 | EP1049482B1 Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0981364B1 Method and compositions for treating hyperlipidemia |
| 03/01/2006 | EP0979241B1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta |
| 03/01/2006 | EP0959873B1 Gel composition and methods |
| 03/01/2006 | EP0956506B1 Treatment and diagnosis of cancer |
| 03/01/2006 | EP0941315B1 Fusion proteins containing stress proteins for inducing immune responses |
| 03/01/2006 | EP0933380B1 Method of searching for physiologically active substances and process for producing the same |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0862634B2 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 03/01/2006 | EP0840750B1 Ha-2 antigenic peptide |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | EP0750507B2 Proteasome regulation of nf-kappa-b activity |
| 03/01/2006 | EP0677105B1 Allergenic proteins and peptides from dog dander and uses therefor |
| 03/01/2006 | CN1742019A Process for the preparation of hypoallergenic mosaic proteins |
| 03/01/2006 | CN1741817A A hepatitis c virus codon optimized non-structural NS3/4A fusion gene |
| 03/01/2006 | CN1741816A Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 03/01/2006 | CN1741814A Modified naturetic compounds, conjugates, and uses thereof |
| 03/01/2006 | CN1741813A Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 03/01/2006 | CN1741812A Modified hemoglobin and methods of making same |
| 03/01/2006 | CN1741811A Use of ROM production and release inhibitors to treat and prevent intraocular damage |
| 03/01/2006 | CN1741810A Glycopeptide antibiotic derivatives |
| 03/01/2006 | CN1741809A Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 03/01/2006 | CN1741808A Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 03/01/2006 | CN1741805A High protein, bowman-birk inhibitor concentrate and process for its manufacture |
| 03/01/2006 | CN1741749A Nutritional compositions |
| 03/01/2006 | CN1741741A Composition and method for treating lupus nephritis |
| 03/01/2006 | CN1740200A Cervical cancer inhibiting fusion protein |
| 03/01/2006 | CN1740198A GLP-1 derivative |
| 03/01/2006 | CN1740197A Recombination interferon with new space conformation and enhanced effect, its preparing method and application |
| 03/01/2006 | CN1740195A Polypeptide gapM1 and its prepn process |
| 03/01/2006 | CN1740194A One kind of tumor relevant protein and its coding gene and application |
| 03/01/2006 | CN1740193A Non-amidated omega-conotoxin VIIA and its prepn process and application |
| 03/01/2006 | CN1740173A Inhibitors of interleukin-1beta converting enzyme |
| 03/01/2006 | CN1739803A Bioactive peptide specific medicine for recurrent late phase cancer |
| 03/01/2006 | CN1739799A Compound recipe for treating osteoarthrosis |
| 03/01/2006 | CN1739798A Biodegradable chewing gum with functions of nursing face, beautifying and slimming |
| 03/01/2006 | CN1739797A Compound recipe for replenishing collagen |
| 03/01/2006 | CN1739796A Slow release parathyroid hormone microballoon |
| 03/01/2006 | CN1739795A Prepn process of slow release parathyroid hormone microballoon |
| 03/01/2006 | CN1739794A Thymosin alpha-1 aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739793A Human granulocyte-macrophage colony stimulating factor spray and its prepn process |
| 03/01/2006 | CN1739792A Externally applied liquid prepn of recombinant human granulocyte-macrophage colony stimulating factor |
| 03/01/2006 | CN1739791A Prevention and treatment of hepatocellular cancer |
| 03/01/2006 | CN1739790A Peptidoglycan immunopotentiator and its production process |
| 03/01/2006 | CN1739789A Somatostation a aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739788A Modulation of TRIP-BR function and method of treating proliferative disorders |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739786A Thymic pentapeptide aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739491A Nanometer fiber slow-releasing system and its prepn process and application |
| 03/01/2006 | CN1243830C Novel mouse CXC chemotactic receptor |
| 03/01/2006 | CN1243779C Hydrophilic polymer derivative having Y shaped branch, its preparation method, combined object with medicine molecule and medical composition containing combined object |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 03/01/2006 | CN1243569C Use of active P40 conjugates for nasal delivery |
| 03/01/2006 | CN1243568C Recombination protein for preventing human trachoma bedsnia infestation and its use |